Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gildan Activewear (GIL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Gildan Activewear (GIL) over the last 17 years, with Q3 2025 value amounting to $98.8 million.

  • Gildan Activewear's Cash & Equivalents rose 943.98% to $98.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.8 million, marking a year-over-year increase of 943.98%. This contributed to the annual value of $98.8 million for FY2025, which is N/A changed from last year.
  • Per Gildan Activewear's latest filing, its Cash & Equivalents stood at $98.8 million for Q3 2025, which was up 943.98% from $98.8 million recorded in Q2 2025.
  • Over the past 5 years, Gildan Activewear's Cash & Equivalents peaked at $505.3 million during Q1 2021, and registered a low of $89.6 million during Q4 2023.
  • Over the past 5 years, Gildan Activewear's median Cash & Equivalents value was $98.8 million (recorded in 2024), while the average stood at $144.6 million.
  • In the last 5 years, Gildan Activewear's Cash & Equivalents surged by 68792.38% in 2021 and then crashed by 6453.34% in 2022.
  • Over the past 5 years, Gildan Activewear's Cash & Equivalents (Quarter) stood at $505.3 million in 2021, then plummeted by 64.53% to $179.2 million in 2022, then crashed by 49.98% to $89.6 million in 2023, then rose by 10.22% to $98.8 million in 2024, then changed by 0.0% to $98.8 million in 2025.
  • Its Cash & Equivalents stands at $98.8 million for Q3 2025, versus $98.8 million for Q2 2025 and $98.8 million for Q1 2025.